Prognostic Stage IIIB Breast Cancer AJCC v8 Clinical Trials

72 clinical trials for Prognostic Stage IIIB Breast Cancer AJCC v8 across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax — RECRUITING · PHASE1
• Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer — RECRUITING · NA
• Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer — RECRUITING · PHASE1
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast Cancer — RECRUITING · PHASE2
• Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer — RECRUITING · PHASE1
• Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Taxane and Taxane-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors — ACTIVE_NOT_RECRUITING
• STEMVAC in Patients With Early Stage Triple Negative Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations — TERMINATED · PHASE2
• Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy — ACTIVE_NOT_RECRUITING · PHASE2
• Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer — ACTIVE_NOT_RECRUITING
• Transcutaneous Electrical Nerve Stimulation in Chemotherapy Induced Peripheral Neuropathy in Patients With Stage I-III Early Stage Breast Cancer — TERMINATED · NA
• Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• Piloting Y-AMBIENT: A Quality of Life Intervention for Young African American Breast Cancer Survivors — TERMINATED · NA
• A Quality of Life Intervention for Young African American Breast Cancer Survivors in Treatment — TERMINATED · NA
• Identifying Decision Making Needs for Older Adult Women With Stage I-III Breast Cancer Considering Neoadjuvant or Adjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · NA
• PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgery — COMPLETED · PHASE1
• Infertility Survey Among Reproductive Age Women With Gynecological and Breast Cancer — ACTIVE_NOT_RECRUITING
• Intensity Modulated Radiation Therapy or 3-Dimensional Conformal Radiation Therapy in Treating Patients With Lymph-Node Positive Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• ALRN-6924 and Paclitaxel in Treating Patients With Advanced, Metastatic, or Unresectable Solid Tumors — COMPLETED · PHASE1
• Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Web-Based Symptom Monitoring and Self-Management Portal (YES) for Adolescent and Young Adult Breast Cancer Survivors — ACTIVE_NOT_RECRUITING · NA
• Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study — COMPLETED
• Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer — COMPLETED · PHASE1
• Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer — COMPLETED
• Radiation Therapy Boost Before Surgery for the Treatment of Non-metastatic Breast Cancer — ACTIVE_NOT_RECRUITING · NA
• Culturally Based Brief Expressive Writing Intervention for the Improvement of Health in Chinese Immigrant Stage 0-III Breast Cancer Survivors, Writing to Heal Study — ACTIVE_NOT_RECRUITING · NA
• Multiscale Omics for the Development of a Cohort Database and Study Platform in Breast Cancer Survivors — COMPLETED
• Abemaciclib in Treating Patients With Surgically Resectable, Chemotherapy Resistant, Triple Negative Breast Cancer — TERMINATED · PHASE2
• Rifaximin for the Treatment of Gastrointestinal Toxicities Related to Pertuzumab-Based Therapy in Patients With Stage I-III HER2 Positive Breast Cancer — TERMINATED · PHASE2
• Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel — COMPLETED · PHASE2
• Nilotinib in Preventing Paclitaxel-Induced Peripheral Neuropathy in Patients With Stage I-III Breast Cancer — COMPLETED · PHASE1
• Mobile Health to Improve Oral Chemotherapy Adherence Among Women With Breast Cancer — COMPLETED · NA
• T-VEC With Chemotherapy or Endocrine Therapy in Treating Participants With HER2- Negative Breast Cancer — COMPLETED · PHASE1
• Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial — COMPLETED · NA
• Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions — ACTIVE_NOT_RECRUITING · NA
• Health Coaching-Based Navigation at the Conclusion of Treatment for the Support of Black Breast Cancer Survivors — COMPLETED · NA
• Nipple Aspirate Fluid in Detecting Breast Cancer — COMPLETED · NA
• Hydroxychloroquine, Palbociclib, and Letrozole Before Surgery in Treating Patients With Estrogen Receptor Positive, HER2 Negative Breast Cancer — COMPLETED · PHASE1
• An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors — COMPLETED · NA
• Anastrozole and Letrozole After Surgery for the Treatment of Stage I-III Breast Cancer — COMPLETED · PHASE2
• Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer — WITHDRAWN · PHASE2
• M7824 in Treating Patients With Stage II-III HER2 Positive Breast Cancer — COMPLETED · PHASE1
• Alpelisib and Enzalutamide in Treating Patients With Androgen Receptor and PTEN Positive Metastatic Breast Cancer — COMPLETED · PHASE1
• Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy — TERMINATED · PHASE2
• Precision Performance Status Assessment in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy — TERMINATED
• Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer — COMPLETED · PHASE1
• A Text-based Intervention in Improving Adherence to Hormone Therapy in Patients With Stage I-III Hormone Receptor Positive Breast Cancer — OTHER · NA
• Durvalumab and Tremelimumab Before Surgery in Treating Patients With Hormone Receptor Positive, HER2 Negative Stage II-III Breast Cancer — COMPLETED · PHASE1

Refine this search